Angela Bertolini

Angela Bertolini

Auto-generated profile, based on publicly available information

Angela Bertolini

Hematology and Transplant Center University Hospital “San Giovanni di Dio e Ruggi d'Aragona” Salerno Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in European Journal of Haematology
Verified
Journal Article
Open access
VGValentina Giudice
Valentina Giudice
BSBianca Serio
Bianca Serio
ABAngela Bertolini
Angela Bertolini
LMLaura Mettivier
Laura Mettivier
FDFrancesca D'ALto
Francesca D'ALto
CSCarmine Selleri
Carmine Selleri
Background: Current chronic lymphocytic leukemia (CLL) International Prognostic Index (IPI) stratifies patients based on clinical, molecular, and biochemical features; however, B‐cell markers also influence CLL outcomes. Here, prognostic roles of CD11c, CD38, and CD49d were first evaluated, and then an immunophenotypic score was combined with CLL‐IPI for risk stratification of CLL patients.Methods: A total of 171 CLL subjects were included, and surface marker expression was assessed by flow cytometry. Levels ≥30% were chosen as cut‐off of positivity to a marker; then values of 1 (for CD11c and CD38) or 3 (for CD49d) were assigned and scores determined for each patient's clone immunophenotype.Results: CD49d positivity was significantly associated with simultaneous expression of CD11c and/or CD38, unmutated IGHV status, and higher β2‐microglobulin levels compared to those with CD49d negativity. Moreover, CD49d+ patients experienced a shorter progression‐free survival and time to treatment. When the immunophenotypic score was combined with CLL‐IPI, patients with high‐risk immunophenotype had a significantly lower time‐to‐treatment regardless CLL‐IPI.Conclusions: Our results suggested clinical utility of an integrated prognostic score for better risk stratification of CLL patients. These results require further validation in prospective larger studies.

27 July 2023 in European Journal of Haematology
Verified
Journal Article
Open access
VGValentina Giudice
Valentina Giudice
BSBianca Serio
Bianca Serio
SESanta Errichiello
Santa Errichiello
IFIdalucia Ferrara
Idalucia Ferrara
AGAlessandra Galdiero
Alessandra Galdiero
CSCarmine Selleri
Carmine Selleri
Background: Splicing modifications, genomic instability, and hypomethylation are central mechanisms promoting myelodysplasia and acute myeloid leukemia (AML). In this real‐life retrospective study, to elucidate pathophysiology of clonal hemopoiesis in hematological malignancies, we investigated clinical significance of mutations in leukemia‐related genes of known pathogenetic significance and of variants of uncertain clinical significance (VUS) in a cohort of patients with MDS and AML.Methods: A total of 59 consecutive subjects diagnosed with MDS, 48 with AML, and 17 with clonal cytopenia with unknown significance were screened for somatic mutations in AML‐related genes by next‐generation sequencing.Results: We showed that TET2, SETBP1, ASXL1, EZH2, RUNX1, SRSF2, DNMT3A, and IDH1/2 were commonly mutated. MDS patients also showed a high genetic complexity, especially for SETBP1. Moreover, the presence of SETBP1 wild‐type or two or more simultaneous VUS variants identified a subgroup of AML and MDS patients with better outcome, while the presence of single SETBP1 VUS variant was related to a worse prognosis, regardless TET2 mutational status.Conclusions: In conclusions, we linked both pathogenic and VUS variants in AML‐related genes to clonal hematopoiesis; therefore, we proposed to consider those variants as prognostic markers in leukemia and myelodysplasia. However, further studies in larger prospective cohorts are required to validate our results.

15 November 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
IRInri Rodrigues
Inri Rodrigues
GPGiovana Punaro
Giovana Punaro
DLDeyse Lima
Deyse Lima
TBTiphany Coralie De Bessa
Tiphany Coralie De Bessa
MMMargaret Mouro
Margaret Mouro
EHElisa Mieko Suemitsu Higa
Elisa Mieko Suemitsu Higa